Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)
Europace · 01.09.2025 · 27 (9)
DOI: 10.1093/europace/euaf139 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Europace, online erschienen am 02.07.2025. Verfasst von Frédéric Sacher und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Arrhythmia Department, IHU Liryc, Univ. Bordeaux, INSERM 1045, CHU de Bordeaux, CMARY, ERN Guard Heart, REFER-RYTHMO Network, F33600 Bordeaux…. Hauptthemen laut MEDLINE: Cardiac Catheters, Catheter Ablation, Tachycardia, Ventricular, Ventricular Fibrillation. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Government as part of the 'Investments in the Future' program managed by the National Research Agency, Grant France 2030, REFER-RYTHMO network.
Abstract (Originalsprache)
Aims
The feasibility and safety of the lattice-tip catheter for ventricular arrhythmia (VA) ablation in humans remain largely unknown. This study aimed to assess feasibility, safety profile as well as patient outcomes after VA ablation with a lattice-tip catheter in a multicentre European registry. Methods and results All 18 European centres using the AFFERA system in September 2024 agreed to participate. Clinical, procedural, and follow-up data (minimum 3 months) were systematically collected and analysed. A total of 126 patients (18% female; mean age 59 ± 16 years) underwent VA ablation using the lattice-tip catheter during the inclusion period. Ablation indications included ventricular tachycardia (VT) in 99, premature ventricular complexes (PVCs) in 23, and ventricular fibrillation (VF) in 4 patients. Major and minor acute complications were observed in 7 (6%) and 18 (14%) procedures, respectively. They included thrombo-embolic event (n = 2), major bleeding (n = 2), ventricular fibrillation induction (n = 1), tamponade due to epicardial access (n = 1), and cardiogenic shock due to prolonged VT mapping (n = 1). Within the first month post-procedure, three patients died [from multi-organ failure (n = 2) and sepsis (n = 1)], two had worsening heart failure, one myocardial infarction, one sepsis, and one major gastro-intestinal bleeding. After a mean follow-up of 5.6 ± 3.7 months, absence of recurrence was 78% for PVC, 70% for VT, and 100% for VF.
Conclusion
In this complex population with refractory VA, ablation using the lattice-tip catheter appears feasible and relatively safe. In the absence of large, randomized trials, exhaustive registry is of key importance to ensure safety and efficacy of new catheter technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Arrhythmia Department, IHU Liryc, Univ. Bordeaux, INSERM 1045, CHU de Bordeaux, CMARY, ERN Guard Heart, REFER-RYTHMO Network, F33600 Bordeaux, France.
- Heart Rhythm Management Centre, Postgraduate Program in Cardiac Electrophysiology and Pacing, Universitair Ziekenhuis Brussel-Vrije Universiteit Brussel, European Reference Networks Guard-Heart, Brussels, Belgium.
- Department of Cardiology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
- Cardioangiologische Centrum Bethanien (CCB), Frankfurt, Germany.
- Department of Pacing and Electrophysiology, Beacon Hospital, Dublin, Ireland.
- Cardiovascular Institute Paris-Sud (ICPS), Jacques Cartier Private Hospital, Massy, France.
ORCID-Profile: Frédéric Sacher, Andrea Sarkozy, Helmut Pürerfellner, Alexandra Steyer, Jonathan Lyne, Charlène Coquard, Romain Tixier, Michel Haissaguerre, Josselin Duchateau, Victor Castro Urda, Claire A Martin, Marc Lemoine, Alejandro Carta Bergaz, Frank Bogun, Nick Linton, Nicolas Derval, Filip Schlosser, Thomas Pambrun, Meleze Hocini, Luigi Pannone, Martin Mudroch, Josef Kautzner, Pierre Jais, Tobias Reichlin, Petr Neužil, Petr Peichl
Förderung
- French Government as part of the 'Investments in the Future' program managed by the National Research Agency
- Grant France 2030
- REFER-RYTHMO network
- French Government as part of the ‘Investments in the Future’ program managed by the National Research Agency
Zitieren
APA
Sacher, F., Sarkozy, A., Pürerfellner, H., Steyer, A., Lyne, J., Coquard, C., Tixier, R., Combes, N., Haissaguerre, M., Efremidis, M., Duchateau, J., Castro Urda, V., Martin, C. A., Lemoine, M., Bergaz, A. C., Bogun, F., Linton, N., Derval, N., Schlosser, F., …, & Peichl, P. (2025). Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR). Europace, 27(9). https://doi.org/10.1093/europace/euaf139
Vancouver
Sacher F, Sarkozy A, Pürerfellner H, Steyer A, Lyne J, Coquard C, et al. Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR). Europace. 2025;27(9). doi:10.1093/europace/euaf139
BibTeX
@article{Sacher2025,
author = {Sacher, Frédéric and Sarkozy, Andrea and Pürerfellner, Helmut and Steyer, Alexandra and Lyne, Jonathan and Coquard, Charlène and Tixier, Romain and Combes, Nicolas and Haissaguerre, Michel and Efremidis, Michalis and Duchateau, Josselin and Castro Urda, Victor and Martin, Claire A and Lemoine, Marc and Bergaz, Alejandro Carta and Bogun, Frank and Linton, Nick and Derval, Nicolas and Schlosser, Filip and Pambrun, Thomas and Petru, Jan and Hocini, Meleze and Pannone, Luigi and Mudroch, Martin and Kautzner, Josef and Jais, Pierre and Reichlin, Tobias and Neužil, Petr and Peichl, Petr},
title = {Safety and efficacy of a lattice-tip catheter for ventricular arrhythmia ablation: the AFFERA Ventricular Arrhythmia Ablation Registry (AVAAR)},
journal = {Europace},
year = {2025},
volume = {27},
number = {9},
doi = {10.1093/europace/euaf139}
}
EUVIMED